ImExHS Limited (AU:IME)
ASX:IME
Want to see AU:IME full AI Analyst Report?
IME Stock Chart & Stats
AU$0.40
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.40
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.22 - AU$0.47
Previous CloseN/A
Volume202.98K
Average Volume (3M)41.77K
Market Cap
AU$20.93M
Enterprise ValueAU$16.19M
Total Cash (Recent Filing)AU$3.30M
Total Debt (Recent Filing)AU$566.32K
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding54,375,668
10 Day Avg. Volume23,052
30 Day Avg. Volume41,775
Financial Highlights & Ratios
PEG Ratio1.98
Price to Book (P/B)1.29
Price to Sales (P/S)0.71
P/FCF Ratio83.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)AU$32.59M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained acceleration in top-line growth indicates stronger product adoption and expanding customer base for the Hiruko platform. Over 2-6 months this supports higher recurring revenues, better scale economics, and provides management optionality to invest in sales, R&D and international expansion without relying on one-off deals.
Low LeverageA conservatively levered balance sheet gives the company financial flexibility to fund operations, absorb losses, and pursue strategic initiatives. Low debt reduces refinancing and interest risk, enabling steady investment in product development and partnerships that underpin long-term competitive positioning.
Recurring SaaS ModelA cloud subscription model and AI-enabled imaging suite create recurring, predictable revenue and higher customer retention through platform lock-in. Multi-year contracts and professional services increase lifetime value, supporting durable cash inflows and making growth more scalable versus one-time license sales.
Bears Say
Persistent LossesOngoing negative profitability undermines return on invested capital and limits ability to self-fund expansion long-term. Continued losses can compress equity returns, force dilution or external funding, and constrain margin recovery even if revenue trends remain positive unless operating leverage improves materially.
Gross Margin ErosionA sharp drop in gross margin signals either pricing pressure, higher delivery costs, or mix shifts that impair scalability. Persistently lower gross margins make it harder to translate revenue growth into sustainable profits and reduce the cushion available for sales, marketing and R&D investments needed to defend market share.
Volatile Cash FlowIntermittent cash generation and prior swings reduce predictability of internal funding for product development and contract fulfillment. Volatility raises the risk of episodic financing needs and complicates planning for multi-quarter investments, undermining the stability expected by partners and enterprise customers.
ImExHS Limited News
IME FAQ
What was ImExHS Limited’s price range in the past 12 months?
ImExHS Limited lowest share price was AU$0.22 and its highest was AU$0.47 in the past 12 months.
What is ImExHS Limited’s market cap?
ImExHS Limited’s market cap is AU$20.93M.
When is ImExHS Limited’s upcoming earnings report date?
ImExHS Limited’s upcoming earnings report date is Aug 31, 2026 which is in 76 days.
How were ImExHS Limited’s earnings last quarter?
ImExHS Limited released its earnings results on Feb 26, 2026. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of -AU$0.015 by AU$0.017.
Is ImExHS Limited overvalued?
According to Wall Street analysts ImExHS Limited’s price is currently Overvalued.
Does ImExHS Limited pay dividends?
ImExHS Limited does not currently pay dividends.
What is ImExHS Limited’s EPS estimate?
ImExHS Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImExHS Limited have?
ImExHS Limited has 54,375,668 shares outstanding.
What happened to ImExHS Limited’s price movement after its last earnings report?
ImExHS Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of -AU$0.015. Following the earnings report the stock price went up 9.756%.
Which hedge fund is a major shareholder of ImExHS Limited?
Currently, no hedge funds are holding shares in AU:IME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ImExHS Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.55%
12-Months-Change
Fundamentals
Return on Equity
-19.01%
Trailing 12-Months
Asset Growth
8.81%
Trailing 12-Months
Company Description
ImExHS Limited
ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.
Technical Analysis
Resonance Health Ltd
―
Beamtree Holdings Ltd
―
―
Singular Health Group Ltd
―
PainChek Ltd
―
Options Prices
Currently, No data available
---